GSK ordered to pay Vectura $89.7m in patent damages
07-05-2019
GSK awarded Arrow declaration in patent dispute with Vectura
17-12-2018
360b / Shutterstock.com
Pharmaceutical company Vectura has sued GSK for allegedly infringing its patent after claiming that it refused to expand on a licensing agreement.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Vectura, GSK, patent, Ellipta, US District Court for the District of Delaware
